Published in Semin Nephrol on September 01, 2010
Integrative biology identifies shared transcriptional networks in CKD. J Am Soc Nephrol (2014) 1.71
Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach. Kidney Int (2013) 1.69
A systems view of genetics in chronic kidney disease. Kidney Int (2011) 1.09
Integrative biology of renal disease: toward a holistic understanding of the kidney's function and failure. Semin Nephrol (2010) 0.83
Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet (2000) 336.52
Bioconductor: open software development for computational biology and bioinformatics. Genome Biol (2004) 143.19
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc (2009) 137.99
Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A (2001) 132.88
Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics (2003) 100.88
dbSNP: the NCBI database of genetic variation. Nucleic Acids Res (2001) 76.97
TM4: a free, open-source system for microarray data management and analysis. Biotechniques (2003) 38.02
The KEGG databases at GenomeNet. Nucleic Acids Res (2002) 33.68
Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A (2002) 30.32
GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol (2003) 22.63
NCBI GEO: archive for high-throughput functional genomic data. Nucleic Acids Res (2008) 17.35
Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application. Genome Biol (2001) 15.02
The PANTHER database of protein families, subfamilies, functions and pathways. Nucleic Acids Res (2005) 13.37
STRING: known and predicted protein-protein associations, integrated and transferred across organisms. Nucleic Acids Res (2005) 10.44
Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol (2003) 9.08
The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02
ArrayExpress--a public database of microarray experiments and gene expression profiles. Nucleic Acids Res (2006) 8.92
Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant (2008) 8.09
Online predicted human interaction database. Bioinformatics (2005) 6.83
Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem (1998) 5.99
The International HapMap Project Web site. Genome Res (2005) 5.96
Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant (2007) 5.39
Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med (2003) 4.35
The Stanford Microarray Database: implementation of new analysis tools and open source release of software. Nucleic Acids Res (2006) 3.66
Microarray analysis and tumor classification. N Engl J Med (2006) 3.35
Global networks of functional coupling in eukaryotes from comprehensive data integration. Genome Res (2009) 2.43
NAViGaTOR: Network Analysis, Visualization and Graphing Toronto. Bioinformatics (2009) 2.34
oPOSSUM: integrated tools for analysis of regulatory motif over-representation. Nucleic Acids Res (2007) 2.32
Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am J Transplant (2007) 2.25
MammaPrint 70-gene signature: another milestone in personalized medical care for breast cancer patients. Expert Rev Mol Diagn (2009) 1.89
Protocol core needle biopsy and histologic Chronic Allograft Damage Index (CADI) as surrogate end point for long-term graft survival in multicenter studies. J Am Soc Nephrol (2003) 1.77
Gene expression fingerprints in human tubulointerstitial inflammation and fibrosis as prognostic markers of disease progression. Kidney Int (2004) 1.72
International variation in the interpretation of renal transplant biopsies: report of the CERTPAP Project. Kidney Int (2001) 1.59
Gene expression patterns in deceased donor kidneys developing delayed graft function after kidney transplantation. Transplantation (2008) 1.54
Markers of cellular senescence in zero hour biopsies predict outcome in renal transplantation. Aging Cell (2008) 1.49
Analysis of the MammaPrint breast cancer assay in a predominantly postmenopausal cohort. Clin Cancer Res (2008) 1.48
The contribution of adhesion molecule expression in donor kidney biopsies to early allograft dysfunction. Transplantation (2001) 1.45
Comparative promoter analysis allows de novo identification of specialized cell junction-associated proteins. Proc Natl Acad Sci U S A (2006) 1.43
Diagnosing rejection in renal transplants: a comparison of molecular- and histopathology-based approaches. Am J Transplant (2009) 1.19
Expression of CTL associated transcripts precedes the development of tubulitis in T-cell mediated kidney graft rejection. Am J Transplant (2005) 1.16
Defining human diabetic nephropathy on the molecular level: integration of transcriptomic profiles with biological knowledge. Rev Endocr Metab Disord (2008) 1.16
Hypoxia response and VEGF-A expression in human proximal tubular epithelial cells in stable and progressive renal disease. Lab Invest (2009) 1.16
Morphogenomics and morphoproteomics: a role for anatomic pathology in personalized medicine. Arch Pathol Lab Med (2009) 1.15
The renal biopsy. Arch Pathol Lab Med (2009) 1.14
The transcriptome of the implant biopsy identifies donor kidneys at increased risk of delayed graft function. Am J Transplant (2007) 1.13
SWOT analysis of Banff: strengths, weaknesses, opportunities and threats of the international Banff consensus process and classification system for renal allograft pathology. Am J Transplant (2007) 1.10
Biomarkers for early and late stage chronic allograft nephropathy by proteogenomic profiling of peripheral blood. PLoS One (2009) 1.03
Molecular correlates of scarring in kidney transplants: the emergence of mast cell transcripts. Am J Transplant (2008) 1.02
Genome-wide gene-expression patterns of donor kidney biopsies distinguish primary allograft function. Lab Invest (2004) 1.01
Molecular pathways involved in loss of kidney graft function with tubular atrophy and interstitial fibrosis. Mol Med (2008) 0.94
Histogenomics: association of gene expression patterns with histological parameters in kidney biopsies. Transplantation (2009) 0.93
Alterations in gene expression in cadaveric vs. live donor kidneys suggest impaired tubular counterbalance of oxidative stress at implantation. Am J Transplant (2004) 0.92
Transforming omics data into context: bioinformatics on genomics and proteomics raw data. Electrophoresis (2006) 0.90
Biomarker candidates for cardiovascular disease and bone metabolism disorders in chronic kidney disease: a systems biology perspective. J Cell Mol Med (2008) 0.86
A dependency graph approach for the analysis of differential gene expression profiles. Mol Biosyst (2009) 0.85
Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol (2008) 3.42
Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial. Transplantation (2009) 2.33
Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus. JAMA Intern Med (2013) 1.78
Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation. J Am Soc Nephrol (2006) 1.73
Mortality in renal transplant recipients given erythropoietins to increase haemoglobin concentration: cohort study. BMJ (2009) 1.61
Statin use is associated with prolonged survival of renal transplant recipients. J Am Soc Nephrol (2008) 1.54
Markers of cellular senescence in zero hour biopsies predict outcome in renal transplantation. Aging Cell (2008) 1.49
Effects of bisphosphonates on bone loss in the first year after renal transplantation--a meta-analysis of randomized controlled trials. Nephrol Dial Transplant (2006) 1.48
Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol (2006) 1.43
The effect of ACE inhibitor and angiotensin II blocker therapy on early posttransplant kidney graft function. Am J Kidney Dis (2004) 1.42
A single nucleotide polymorphism at chromosome 2q21.3 (LCT -13910C>T) associates with clinical outcome after allogeneic hematopoietic stem cell transplantation. Blood (2008) 1.39
Cost-effectiveness analysis of renal replacement therapy in Austria. Nephrol Dial Transplant (2011) 1.38
Impaired tubulointerstitial expression of endothelin-1 and nitric oxide isoforms in donor kidney biopsies with postischemic acute renal failure. Transplantation (2003) 1.37
Mitochondrial regulation of apoptosis. News Physiol Sci (2003) 1.33
Predictors of new-onset decline in kidney function in a general middle-european population. Nephrol Dial Transplant (2007) 1.29
Health-related quality of life outcomes after kidney transplantation. Health Qual Life Outcomes (2004) 1.21
Hypoxia response and VEGF-A expression in human proximal tubular epithelial cells in stable and progressive renal disease. Lab Invest (2009) 1.16
Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal. J Am Soc Nephrol (2004) 1.12
Rational decision making in the treatment of renal artery stenosis. Wien Klin Wochenschr (2002) 1.08
Pimecrolimus identifies a common genomic anti-inflammatory profile, is clinically highly effective in psoriasis and is well tolerated. J Invest Dermatol (2002) 1.02
Genome-wide gene-expression patterns of donor kidney biopsies distinguish primary allograft function. Lab Invest (2004) 1.01
Steroid pretreatment of organ donors to prevent postischemic renal allograft failure: a randomized, controlled trial. Ann Intern Med (2010) 1.00
Association of ESA hypo-responsiveness and haemoglobin variability with mortality in haemodialysis patients. Nephrol Dial Transplant (2010) 0.99
Sirolimus in renal transplant recipients with tuberous sclerosis complex: clinical effectiveness and implications for innate immunity. Transpl Int (2010) 0.96
miRNA profiling discriminates types of rejection and injury in human renal allografts. Transplantation (2013) 0.96
Microarray and bioinformatics analysis of gene expression in experimental membranous nephropathy. Nephron Exp Nephrol (2009) 0.93
Histogenomics: association of gene expression patterns with histological parameters in kidney biopsies. Transplantation (2009) 0.93
Gene-expression profiles and age of donor kidney biopsies obtained before transplantation distinguish medium term graft function. Transplantation (2007) 0.93
Can we really predict the change in serum sodium levels? An analysis of currently proposed formulae in hypernatraemic patients. Nephrol Dial Transplant (2008) 0.92
Alterations in gene expression in cadaveric vs. live donor kidneys suggest impaired tubular counterbalance of oxidative stress at implantation. Am J Transplant (2004) 0.92
Biomarkers in renal transplantation ischemia reperfusion injury. Transplantation (2009) 0.92
mTOR inhibition: the learning curve in kidney transplantation. Transpl Int (2010) 0.91
Hemoglobin variability after renal transplantation is associated with mortality. Transpl Int (2012) 0.91
Differential expression of alphaB-crystallin and Hsp27-1 in anaplastic thyroid carcinomas because of tumor-specific alphaB-crystallin gene (CRYAB) silencing. Cell Stress Chaperones (2005) 0.90
Mapping of molecular pathways, biomarkers and drug targets for diabetic nephropathy. Proteomics Clin Appl (2011) 0.90
Regression methods for investigating risk factors of chronic kidney disease outcomes: the state of the art. BMC Nephrol (2014) 0.90
Transforming omics data into context: bioinformatics on genomics and proteomics raw data. Electrophoresis (2006) 0.90
Zoledronic acid to prevent bone loss in the first 6 months after renal transplantation. Kidney Int (2003) 0.89
Sirolimus induced phosphaturia is not caused by inhibition of renal apical sodium phosphate cotransporters. PLoS One (2012) 0.87
Gene expression and biomarkers in renal transplant ischemia reperfusion injury. Transpl Int (2007) 0.87
Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial. Trials (2014) 0.87
Nonsustained effect of short-term bisphosphonate therapy on bone turnover three years after renal transplantation. Kidney Int (2004) 0.86
Biomarker candidates for cardiovascular disease and bone metabolism disorders in chronic kidney disease: a systems biology perspective. J Cell Mol Med (2008) 0.86
Flow monitoring: performance characteristics of ultrasound dilution versus color Doppler ultrasound compared with fistulography. Am J Kidney Dis (2003) 0.86
Tubular apoptosis in the pathophysiology of renal disease. Wien Klin Wochenschr (2002) 0.86
Renal microRNA- and RNA-profiles in progressive chronic kidney disease. Eur J Clin Invest (2016) 0.85
ACE-inhibitor or AT2-antagonist therapy of renal transplant recipients is associated with an increase in serum potassium concentrations. Nephrol Dial Transplant (2008) 0.85
The effect of steroid pretreatment of deceased organ donors on liver allograft function: a blinded randomized placebo-controlled trial. J Hepatol (2012) 0.85
Body mass index modifies the risk of cardiovascular death in proteinuric chronic kidney disease. Nephrol Dial Transplant (2009) 0.84
Factors influencing glomerular filtration rate in renal transplantation after cyclosporine withdrawal using sirolimus-based therapy: a multivariate analysis of results at five years. Clin Transplant (2007) 0.84
Molecular biomarker candidates of acute kidney injury in zero-hour renal transplant needle biopsies. Transpl Int (2010) 0.84
Olfactory function in chronic renal failure. Am J Rhinol (2002) 0.83
Impaired metabolism in donor kidney grafts after steroid pretreatment. Transpl Int (2010) 0.83
Detection of coregulation in differential gene expression profiles. Biosystems (2005) 0.83
Anemia and erythrocytosis in patients after kidney transplantation. Transpl Int (2012) 0.83
The association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use during postischemic acute transplant failure and renal allograft survival. Transplantation (2006) 0.83
Regression of hypertensive nephropathy during three years of optimal blood pressure control. Wien Klin Wochenschr (2003) 0.82
Incidence of anemia in sirolimus-treated renal transplant recipients: the importance of preserving renal function. Transpl Int (2007) 0.82
Diagnostic Contribution of Donor-Specific Antibody Characteristics to Uncover Late Silent Antibody-Mediated Rejection-Results of a Cross-Sectional Screening Study. Transplantation (2017) 0.82
Linking transcriptomic and proteomic data on the level of protein interaction networks. Electrophoresis (2010) 0.82
Discrete simulation of regulatory homo- and heterodimerization in the apoptosis effector phase. Bioinformatics (2002) 0.82
Transcriptional response in the unaffected kidney after contralateral hydronephrosis or nephrectomy. Kidney Int (2005) 0.81
Superior outcomes in renal transplantation after early cyclosporine withdrawal and sirolimus maintenance therapy, regardless of baseline renal function. Transplantation (2005) 0.81
Glucose control is associated with patient survival in diabetic patients after renal transplantation. Transplantation (2010) 0.81
Molecular pathways and crosstalk characterizing the cardiorenal syndrome. OMICS (2012) 0.81
Effect of intraportal infusion of tacrolimus on ischaemic reperfusion injury in orthotopic liver transplantation: a randomized controlled trial. Transpl Int (2011) 0.81
The effect of fluid intake on chronic kidney transplant failure: a pilot study. J Ren Nutr (2011) 0.81
Treatment with oral active vitamin D is associated with decreased risk of peritonitis and improved survival in patients on peritoneal dialysis. PLoS One (2013) 0.80
Complete renal tubular acidosis late after kidney transplantation. Nephrol Dial Transplant (2006) 0.80
Osteoprotegerin and parathyroid hormone as markers of high-turnover osteodystrophy and decreased bone mineralization in hemodialysis patients. Am J Kidney Dis (2002) 0.80
Metallothioneins and renal ageing. Nephrol Dial Transplant (2016) 0.80
Calcineurin inhibitor-based immunosuppressive therapy, donor age, and long-term outcome after kidney transplantation. Transplantation (2009) 0.79
Failure of BCL-2 up-regulation in proximal tubular epithelial cells of donor kidney biopsy specimens is associated with apoptosis and delayed graft function. Lab Invest (2002) 0.79
Calcineurin inhibitor minimization, withdrawal and avoidance protocols after kidney transplantation. Transpl Int (2008) 0.79
Does size matter? Nephrol Dial Transplant (2007) 0.79
Body mass index is the main risk factor for arterial hypertension in young subjects without major comorbidity. Eur J Clin Invest (2003) 0.79
Late Antibody-Mediated Rejection in a Large Prospective Cross-Sectional Study of Kidney Allograft Recipients--Preliminary Results of the Screening Phase of the BORTEJECT Trial. Clin Transpl (2014) 0.78
Renal phosphate handling in human--what can we learn from hereditary hypophosphataemias? Eur J Clin Invest (2010) 0.78
Kidney injury molecule-1 as a biomarker of acute kidney injury in renal transplant recipients. Nat Clin Pract Nephrol (2008) 0.78
The case: hemolysis and acute renal failure. Babesiosis. Kidney Int (2011) 0.78
Age and sex are sufficient for predicting fractures occurring within 1 year of hemodialysis treatment. Bone (2006) 0.78
Omics-bioinformatics in the context of clinical data. Methods Mol Biol (2011) 0.77
Left atrial diameter and survival among renal allograft recipients. Clin J Am Soc Nephrol (2013) 0.77
Effects of AT1 and AT2 receptor blockade on angiotensin II induced apoptosis of human renal proximal tubular epithelial cells. Wien Klin Wochenschr (2002) 0.77
Autologous stem-cell transplantation in progressing amyloidosis is associated with severe transplant-related toxicity. Wien Klin Wochenschr (2006) 0.77
Bone disease after kidney transplantation. Transpl Int (2008) 0.77
Developing Consensus-Based Priority Outcome Domains for Trials in Kidney Transplantation: A Multinational Delphi Survey With Patients, Caregivers, and Health Professionals. Transplantation (2017) 0.76
Antithymocyte globulin use for treatment of biopsy confirmed acute rejection is associated with prolonged renal allograft survival. Transpl Int (2009) 0.76
The future role of target of rapamycin inhibitors in renal transplantation. Curr Opin Urol (2002) 0.76
Biocompatibility of peritoneal dialysis solutions determined by genomics of human leucocytes: a cross-over study. NDT Plus (2009) 0.75
Calcineurin inhibitor withdrawal from sirolimus-based therapy in kidney transplantation: a systematic review of randomized trials. Am J Transplant (2005) 0.75
Integrative bioinformatics analysis of proteins associated with the cardiorenal syndrome. Int J Nephrol (2010) 0.75
Effects of microinjection of synthetic Bcl-2 domain peptides on apoptosis of renal tubular epithelial cells. Am J Physiol Renal Physiol (2002) 0.75
The 9th International Wyeth Transplantation Symposium: "Phases, stages and risk factors-considering new immunosuppressive strategies for renal transplant patients." Foreword. Transplant Proc (2009) 0.75
Mycophenolate mofetil use is associated with prolonged graft survival after kidney transplantation. Transplantation (2009) 0.75
Molecular signature of mice T lymphocytes following tolerance induction by allogeneic BMT and CD40-CD40L costimulation blockade. Transpl Int (2006) 0.75
Neuroendocrine carcinomas arising in solid-organ transplant recipients: rare but aggressive malignancies. Oncology (2009) 0.75
Optimizing hypertension management in renal transplantation: a call to action. J Hypertens (2017) 0.75
Non-persistent effect of short-term bisphosphonate treatment in preventing fractures after liver transplantation. Transpl Int (2009) 0.75